Archean Chemical Industries Limited has entered into a significant loan agreement with its wholly owned subsidiary to support the advancement of its semiconductor manufacturing operations. The company disclosed this development through a regulatory filing on March 26, 2026, pursuant to SEBI listing regulations.

Loan Agreement Details

The loan agreement involves funding of ₹260 crores extended to Neun Infra Private Limited, the company's wholly owned subsidiary. This financial arrangement is specifically designed to support the procurement of critical manufacturing infrastructure for semiconductor operations.

Purpose and Strategic Context

The loan is intended to fund the procurement of long-lead machinery, equipment, and associated items required for the compound semiconductor manufacturing facility of SiCSem Private Limited. This funding forms part of the overall capital expenditure outlay for the semiconductor manufacturing facility and supports the timely advancement of capital commitments for the project.

Neun Infra Private Limited serves as the holding company for SiCSem Private Limited, which has received approval under the India Semiconductor Mission (ISM) of the Government of India for setting up a compound semiconductor and ATMP manufacturing facility in India.

Financial Structure and Compliance

The transaction qualifies as a related party transaction conducted at arm's length, given the subsidiary relationship between the parties. Archean Chemical Industries Limited holds 100% equity in Neun Infra Private Limited, establishing it as a wholly owned subsidiary.

Regulatory Disclosure

The company has fulfilled its disclosure obligations under Regulation 30 read with Schedule III Para B Part A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Vijayaraghavan N E, Company Secretary and Compliance Officer, and has been made available on the company's website at www.archeanchemicals.com .

This loan agreement represents a strategic investment in India's semiconductor manufacturing capabilities, aligning with the government's semiconductor mission objectives and supporting the development of critical technology infrastructure.

Archean Chemical Industries has announced the approval of a merger between two of its subsidiaries, ICPL and IMPL. This corporate development represents a significant step in the company's organizational restructuring efforts.

Corporate Restructuring Initiative

The merger approval between ICPL and IMPL demonstrates the company's strategic approach to consolidating its subsidiary operations. This consolidation move is designed to streamline the organizational structure and enhance operational efficiency across the group.

Strategic Implications

The approved merger reflects Archean Chemical Industries' commitment to optimizing its corporate framework. By combining these two entities, the company aims to create synergies and improve overall operational effectiveness within its business ecosystem.

Next Steps

With the merger approval now in place, the company will likely proceed with the necessary regulatory and administrative processes required to complete the consolidation of ICPL and IMPL under the unified structure.